top of page!news/yskel/BIO

June 17, 2020

SAN JOSE, Calif.— Jun 17, 2020: Crop Enhancement Inc., an innovator of sustainable plant-based crop-protection products that protect or enhance crop yields, announced the appointment of Jean Pougnier to CEO from his former role as chief business officer, succeeding Kevin Chen, Ph.D., who moves to a new role as an independent board director of the company, effective June 22.

June 16, 2020

BOSTON, June 16, 2020 – GreenLight Biosciences today announced it has raised an oversubscribed $102 million round of funding from new and existing investors to rapidly expand production of its RNA products for agricultural and life sciences applications, including an expansion into new RNA-based therapies. The round was led by Morningside Ventures, with several new and existing top-tier investors including the agriculture venture firm, S2G Ventures, Cormorant Asset Management, Continental Grain CompanyFall Line CapitalTao Capital PartnersBaird CapitalMLS Capital Fund IILewis and Clark AgriFood, and Lupa Systems.

June 10, 2020

CLOUD, MINNESOTA, June 10th, 2020 – Ag-tech startup Consumer Physics is unveiling the world’s first corn moisture analysis solution that provides results in seconds, in the field, directly on the cob, without shelling. The solution is based on SCiO – Consumer Physics’ micro-NIR flagship platform, which is also the world’s first pocket-sized connected micro-spectrometer.

May 12, 2020

GreenLight Biosciences today announced it has closed an oversubscribed $17M special purpose funding round from new and existing investors to build out its scalable mRNA production capability targeting the production of billions of doses of COVID-19 vaccine. In addition to expanding its manufacturing capacity, GreenLight is developing several differentiated mRNA vaccine candidates against SARS-CoV2, the virus responsible for COVID-19. This initiative is an integral part of the company’s expansion into life sciences, which include efforts to develop a large-scale vaccine platform targeting seasonal and pandemic influenza, and rapid response to emerging viruses, such as the novel coronavirus.

April 30, 2020

BERKELEY, CA – APRIL 30, 2020 – Pivot Bio announced today the close of its $100 million Series C funding round co-led by return investors Breakthrough Energy Ventures and global investment company Temasek. Seed and Series A lead and Series B investor, DCVC, also materially participated in the round. With this new funding, Pivot Bio will accelerate its plans to scale its first-to-market microbial nitrogen technology that increases crop yields and farmer revenue. The technology will also aid in decreasing greenhouse gas emissions, water pollution, and global energy use related to the $65 billion global synthetic nitrogen fertilizer market. Pivot Bio PROVEN™, the company’s inaugural product for corn, consistently delivers more nitrogen into the crop than synthetic nitrogen, translating to an average of 5.8 bushels per acre advantage when compared to fields using only synthetic nitrogen in 2019.

April 14, 2020

Additional funding enables agtech innovator to capitalize on near-term opportunities to bring much-needed sustainable solutions to market; investors include Spruce Capital Partners/MLS, 1955 Capital, Phoenix Venture Partners, Cavallo Ventures, Davinia Investment Ltd., and Alexandria Ventures

December 10, 2019

BOULDER, Colo.--(BUSINESS WIRE)--Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/FT. Paladin Capital Group led the round, bringing the total amount raised by the company to $259.5 million. The new funds will be used to accelerate applications expansion and commercialization of the company’s revolutionary Onyx™ Digital Genome Engineering platform.

Serial Biotech Entrepreneur Kevin Ness Has Raised $260 Million To Get His Genome-Engineering Device Into The Hands Of Every Scientist Who Wants One

December 05, 2019

The Rabobank Award for Emerging Leadership in Innovation is given to a fast-growing young company that is addressing challenges and market gaps in F&A with a novel and disruptive business model. The 2019 award is presented to Berkeley, California-based Pivot Bio, a company that provides a microbial nitrogen crop nutrition solution to farmers that reduces the use of synthetic nitrogen fertilizers, helping farmers improve their profitability and sustainability. Pivot Bio was recognized as one of the Most Innovative AgTech Startups of 2018 by Forbes and one of the World’s Most Innovative Companies in 2019 by Fast Company. 

October 01, 2019

The Onyx™ platform enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully automated workflow.

Inscripta, Inc., today announced the launch of the Onyx™ Digital Genome Engineering platform, the world’s first fully automated benchtop instrument for genome-scale engineering. The CRISPR-mediated, massively parallel platform — which includes software, consumables, instrument, and assays — enables researchers to engineer microbial libraries containing the full breadth and scope of possible edit types, in their own labs. This new genome engineering platform will offer immediate and significant benefits that will support bio-industrial materials development and manufacturing, genome discovery, healthcare, and sustainability. 

hat makes it interesting? Write a catchy description to grab your audience's attention...

October 15, 2019

SANTA MONICA, Calif., Oct. 15, 2019 /PRNewswire/ -- Provivi, Inc., an emerging crop protection company, today announced it has completed an $85 million Series C financing. The round was co-led by Pontifax Global Food and Agriculture Fund ("Pontifax Agtech") and a global investment fund. The round also included new investor Tybourne Capital Management. Existing investors Kairos Ventures, Spruce Capital, Lanx Capital, and BASF Venture Capital also participated in the round.

"The Series C financing is a significant milestone in the growth of our company and builds upon an exciting year where we scaled the production of key pheromone active ingredients, continued to demonstrate the efficacy of our products in row crops, and worked closely with farmers to demonstrate the value being created by our pheromones in field trials," said Dr. Pedro Coelho, co-founder and CEO of Provivi. "The extraordinary conditions facing growers all over the world caused by invasive pests renews our sense of urgency to scale our solutions."

Additional coverage:  AgFunder

1 / 8

Please reload

bottom of page